Ionic Pharmaceuticals leverages polymer chemistry and biomedical engineering to develop innovative solutions to clinical challenges. Our strategies exploit the fundamental pathophysiology underlying a disease state to guide the development of our therapies.
As a spin-out of Boston University, we aim to improve the outcomes and quality-of-life for patients through the development and commercialization of new biomaterials, devices and drug-delivery systems.See the awards and support Ionic Pharmaceuticals has received so far on the road of research.
As a spin-out of Boston University, we aim to improve the outcomes and quality-of-life for patients through the development and commercialization of new biomaterials, devices and drug-delivery systems.See the awards and support Ionic Pharmaceuticals has received so far on the road of research.
Services
Our nanoparticle drug-delivery platform reduces local cancer recurrence. By locally and safely delivering chemotherapeutics to residual tumors following a resection surgery, we treat the primary cause of mortality in ovarian, mesothelioma and other peritoneal cancers. This technology accesses a $1B+ (USA) addressable market.
Daily burn wound dressing changes are excruciatingly painful and, despite the use of opioids, cause significant psychological trauma to patients and caregivers alike. Our wound dressing can be sprayed-on and sprayed (dissolved)-off of wounds thereby reducing or eliminating the pain associated with wound dressing changes.
Reviews
Be the first to review Ionic Pharmaceuticals.
Write a Review
